- Home
- Publications
- Publication Search
- Publication Details
Title
The BCG Vaccine for COVID-19: First Verdict and Future Directions
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-03-08
DOI
10.3389/fimmu.2021.632478
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Is global BCG vaccination‐induced trained immunity relevant to the progression of SARS‐CoV‐2 pandemic?
- (2020) Mayda Gursel et al. ALLERGY
- Is BCG vaccination affecting the spread and severity of COVID‐19?
- (2020) Cevdet Ozdemir et al. ALLERGY
- SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues
- (2020) Carly G.K. Ziegler et al. CELL
- SARS-CoV-2 Rates in BCG-Vaccinated and Unvaccinated Young Adults
- (2020) Uri Hamiel et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Considering BCG vaccination to reduce the impact of COVID-19
- (2020) Nigel Curtis et al. LANCET
- New live attenuated tuberculosis vaccine MTBVAC induces trained immunity and confers protection against experimental lethal pneumonia
- (2020) Raquel Tarancón et al. PLoS Pathogens
- Strong homology between SARS-CoV-2 envelope protein and a Mycobacterium sp. antigen allows rapid diagnosis of Mycobacterial infections and may provide specific anti-SARS-CoV-2 immunity via the BCG vaccine
- (2020) Gerard Nuovo et al. Annals of Diagnostic Pathology
- BCG vaccine protection from severe coronavirus disease 2019 (COVID-19)
- (2020) Luis E. Escobar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Activate: Randomized Clinical Trial of BCG Vaccination against Infection in the Elderly
- (2020) Evangelos J. Giamarellos-Bourboulis et al. CELL
- The bacillus Calmette–Guérin vaccination allows the innate immune system to provide protection from severe COVID-19 infection
- (2020) Vincenzo Patella et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- BCG vaccination history associates with decreased SARS-CoV-2 seroprevalence across a diverse cohort of health care workers
- (2020) Magali Noval Rivas et al. JOURNAL OF CLINICAL INVESTIGATION
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
- (2020) Yanjun Zhang et al. LANCET INFECTIOUS DISEASES
- Non-specific effects of BCG vaccine on viral infections
- (2019) S.J.C.F.M. Moorlag et al. CLINICAL MICROBIOLOGY AND INFECTION
- The influence of neonatal Bacille Calmette-Guérin (BCG) immunisation on heterologous vaccine responses in infants
- (2019) Petra Zimmermann et al. VACCINE
- Priming With Recombinant BCG Expressing Novel HIV-1 Conserved Mosaic Immunogens and Boosting With Recombinant ChAdOx1 Is Safe, Stable, and Elicits HIV-1-Specific T-Cell Responses in BALB/c Mice
- (2019) Athina Kilpeläinen et al. Frontiers in Immunology
- The Humoral Immune Response to BCG Vaccination
- (2019) Rachel Tanner et al. Frontiers in Immunology
- BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity
- (2018) Rob J.W. Arts et al. Cell Host & Microbe
- Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination
- (2018) Elisa Nemes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Development of a Live Recombinant BCG Expressing Human Immunodeficiency Virus Type 1 (HIV-1) Gag Using a pMyong2 Vector System: Potential Use As a Novel HIV-1 Vaccine
- (2018) Byoung-Jun Kim et al. Frontiers in Immunology
- Trained Immunity-Based Vaccines: A New Paradigm for the Development of Broad-Spectrum Anti-infectious Formulations
- (2018) Silvia Sánchez-Ramón et al. Frontiers in Immunology
- A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in mice
- (2017) Pablo F. Céspedes et al. VACCINE
- A safe and efficient BCG vectored vaccine to prevent the disease caused by the human Respiratory Syncytial Virus
- (2017) Emma Rey-Jurado et al. Human Vaccines & Immunotherapeutics
- The Recombinant Bacille Calmette–Guérin Vaccine VPM1002: Ready for Clinical Efficacy Testing
- (2017) Natalie E. Nieuwenhuizen et al. Frontiers in Immunology
- Vaccinations against smallpox and tuberculosis are associated with better long-term survival: a Danish case-cohort study 1971–2010
- (2016) Andreas Rieckmann et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Duration of BCG protection against tuberculosis and change in effectiveness with time since vaccination in Norway: a retrospective population-based cohort study
- (2016) Patrick Nguipdop-Djomo et al. LANCET INFECTIOUS DISEASES
- Variable Virulence and Efficacy of BCG Vaccine Strains in Mice and Correlation With Genome Polymorphisms
- (2016) Lu Zhang et al. MOLECULAR THERAPY
- Nonspecific effect of BCG vaccination at birth on early childhood infections: a randomized, clinical multicenter trial
- (2016) Jesper Kjærgaard et al. PEDIATRIC RESEARCH
- Mucosal BCG Vaccination Induces Protective Lung-Resident Memory T Cell Populations against Tuberculosis
- (2016) Carolina Perdomo et al. mBio
- Loss of Lipid Virulence Factors Reduces the Efficacy of the BCG Vaccine
- (2016) Vanessa Tran et al. Scientific Reports
- Genomic expression catalogue of a global collection of BCG vaccine strains show evidence for highly diverged metabolic and cell-wall adaptations
- (2015) Abdallah M. Abdallah et al. Scientific Reports
- BCG-induced trained immunity in NK cells: Role for non-specific protection to infection
- (2014) Johanneke Kleinnijenhuis et al. CLINICAL IMMUNOLOGY
- Virus-Specific Memory CD8 T Cells Provide Substantial Protection from Lethal Severe Acute Respiratory Syndrome Coronavirus Infection
- (2014) R. Channappanavar et al. JOURNAL OF VIROLOGY
- Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity
- (2014) S. Saeed et al. SCIENCE
- Immunization with a Recombinant Bacillus Calmette-Guerin Strain Confers Protective Th1 Immunity against the Human Metapneumovirus
- (2013) C. E. Palavecino et al. JOURNAL OF IMMUNOLOGY
- Long-Lasting Effects of BCG Vaccination on Both Heterologous Th1/Th17 Responses and Innate Trained Immunity
- (2013) Johanneke Kleinnijenhuis et al. Journal of Innate Immunity
- Treatment of Common and Plane Warts in Children with Topical Viable Bacillus Calmette-Guerin
- (2012) Ahmed Salem et al. PEDIATRIC DERMATOLOGY
- Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes
- (2012) J. Kleinnijenhuis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Trained Immunity: A Memory for Innate Host Defense
- (2011) Mihai G. Netea et al. Cell Host & Microbe
- The non-specific effects of vaccines
- (2010) F. Shann ARCHIVES OF DISEASE IN CHILDHOOD
- Efficient Lung Recruitment of Respiratory Syncytial Virus-Specific Th1 Cells Induced by Recombinant Bacillus Calmette-Guerin Promotes Virus Clearance and Protects from Infection
- (2010) K. M. Cautivo et al. JOURNAL OF IMMUNOLOGY
- The therapeutic potential of recombinant BCG expressing the antigen S1PT in the intravesical treatment of bladder cancer
- (2009) Priscila M. Andrade et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started